193 related articles for article (PubMed ID: 23795946)
21. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene.
Akasaka T; Akasaka H; Ueda C; Yonetani N; Maesako Y; Shimizu A; Yamabe H; Fukuhara S; Uchiyama T; Ohno H
J Clin Oncol; 2000 Feb; 18(3):510-18. PubMed ID: 10653866
[TBL] [Abstract][Full Text] [Related]
22. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas.
Wongchaowart NT; Kim B; Hsi ED; Swerdlow SH; Tubbs RR; Cook JR
J Cutan Pathol; 2006 Apr; 33(4):286-92. PubMed ID: 16630178
[TBL] [Abstract][Full Text] [Related]
23. Elucidating a false-negative
Peterson JF; Pitel BA; Smoley SA; Vasmatzis G; Smadbeck JB; Greipp PT; Ketterling RP; Macon WR; Baughn LB
Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160360
[TBL] [Abstract][Full Text] [Related]
24. [Round robin test for detection of genomic aberrations in non-Hodgkin lymphoma by in situ hybridization].
Barth TF; Floßbach L; Bernd HW; Bob R; Buck M; Cogliatti SB; Feller AC; Hansmann ML; Hartmann S; Horn H; Klapper W; Kradolfer D; Mattfeldt T; Möller P; Rosenwald A; Stein H; Thorns C; Ott G
Pathologe; 2013 Jul; 34(4):329-34. PubMed ID: 23179209
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experience.
Foot NJ; Dunn RG; Geoghegan H; Wilkins BS; Neat MJ
J Clin Pathol; 2011 Sep; 64(9):802-8. PubMed ID: 21593346
[TBL] [Abstract][Full Text] [Related]
26. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
[TBL] [Abstract][Full Text] [Related]
27. Burkitt lymphoma: interpreting FISH testing for
Sharma P; Singal S; Costello P; Krishnan K
BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35135797
[TBL] [Abstract][Full Text] [Related]
28. Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature.
Reddy K; Satyadev R; Bouman D; Hibbard MK; Lu G; Paolo R
Cancer Genet Cytogenet; 2006 Apr; 166(1):12-21. PubMed ID: 16616107
[TBL] [Abstract][Full Text] [Related]
29. Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia.
Kobayashi S; Taki T; Chinen Y; Tsutsumi Y; Ohshiro M; Kobayashi T; Matsumoto Y; Kuroda J; Horiike S; Nishida K; Taniwaki M
Genes Chromosomes Cancer; 2011 Apr; 50(4):207-16. PubMed ID: 21319257
[TBL] [Abstract][Full Text] [Related]
30. Semi-quantitative fluorescence in situ hybridization analysis indicates that the myc protein is consistently stabilized both before and after transformation of low-grade follicular center to high-grade diffuse large cell lymphoma.
Albalwi M; Hammond DW; Goepel JR; Hough RE; Goyns MH
Lab Invest; 1999 Jun; 79(6):707-15. PubMed ID: 10378513
[TBL] [Abstract][Full Text] [Related]
31. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
[TBL] [Abstract][Full Text] [Related]
32. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Stejskalová E; Kabícková E
Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
[TBL] [Abstract][Full Text] [Related]
33. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
[TBL] [Abstract][Full Text] [Related]
34. Comparison Between Integrated Genomic DNA/RNA Profiling and Fluorescence In Situ Hybridization in the Detection of MYC, BCL-2, and BCL-6 Gene Rearrangements in Large B-Cell Lymphomas.
Cassidy DP; Chapman JR; Lopez R; White K; Fan YS; Casas C; Severson EA; Vega F
Am J Clin Pathol; 2020 Feb; 153(3):353-359. PubMed ID: 31872861
[TBL] [Abstract][Full Text] [Related]
35. Burkitt lymphoma arising from lymphoplasmacytic lymphoma following acquisition of MYC translocation and loss of the ETV6 tumor suppressor gene.
Peker D; Quigley B; Qin D; Papenhausen P; Zhang L
Arch Pathol Lab Med; 2013 Jan; 137(1):130-3. PubMed ID: 23276184
[TBL] [Abstract][Full Text] [Related]
36. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
37. [Detection of translocations diagnostic for Berkitt's lymphoma by fluorescent in situ hybridization on histological sections of paraffin blocks].
Obukhova TN; Bariakh EA; Kaplanskaia IB; Domracheva EB; Kravchenko SK
Ter Arkh; 2007; 79(7):80-3. PubMed ID: 17802797
[TBL] [Abstract][Full Text] [Related]
38. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.
Havelange V; Ameye G; Théate I; Callet-Bauchu E; Mugneret F; Michaux L; Dastugue N; Penther D; Barin C; Collonge-Rame MA; Baranger L; Terré C; Nadal N; Lippert E; Laï JL; Cabrol C; Tigaud I; Herens C; Hagemeijer A; Raphael M; Libouton JM; Poirel HA;
Genes Chromosomes Cancer; 2013 Jan; 52(1):81-92. PubMed ID: 23012230
[TBL] [Abstract][Full Text] [Related]
39. [Clinical characteristics of high-grade B-cell lymphomas with rearrangement of MYC, bcl-6 and bcl-2].
Gong JY; Zhang YZ; Zhang JD; Zhang W; Li JQ; Ru K; Liu EB
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):14-18. PubMed ID: 29325245
[No Abstract] [Full Text] [Related]
40. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).
da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR
Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
